CNCE
Concert Pharmaceuticals, Inc.
CNCE
CNCE
Delisted
CNCE was delisted on the 3rd of March, 2023.
79 hedge funds and large institutions have $219M invested in Concert Pharmaceuticals, Inc. in 2017 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 27 increasing their positions, 21 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
79
Holders Change
–
Holders Change %
0%
% of All Funds
1.97%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
15
Increased
27
Reduced
21
Closed
14
Calls
$592K
Puts
$220K
Net Calls
+$372K
Net Calls Change
+$882K
Top Buyers
| 1 |
BI
BVF Inc
San Francisco,
California
|
$46.2M |
| 2 |
SM
Senvest Management
New York
|
$4.64M |
| 3 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
$3.62M |
| 4 |
UBS Group
Zurich,
Switzerland
|
$3.81M |
| 5 |
ISL
Ingalls & Snyder LLC
New York
|
$17.8M |
